Surgical Treatment of Bony and Soft-Tissue Impingement in Total Ankle Arthroplasty.

Published

Journal Article

Impingement may be an underreported problem following modern total ankle replacements (TARs). The etiology of impingement is unclear and likely multifactorial. Because of the lack of conservative treatment options for symptomatic impingement after TAR, surgery is often necessary.We retrospectively identified a consecutive series of 1001 primary TARs performed between January 1998 and December 2014. We identified patients who required a secondary surgery to treat soft-tissue and bony impingement by either an open or arthroscopic procedure. Functional and clinical outcomes, including secondary procedures, infections, complications, and failure rates, were recorded.In all, 75 patients (7.5%) required either open (n = 49) or arthroscopic debridement for impingement after TAR; 44 patients had >12 months of follow-up, with a follow-up of 26.5 months after their debridement procedure. The mean time to the debridement procedure for all prostheses was 29.3 months, with an average of 38.7 months in STAR, 21.8 months in INBONE, and 10.5 months in Salto Talaris patients. Of the patients with more than 1 year's follow-up from their debridement, 84.1% were asymptomatic; 9 patients (20.4%) had repeat operations after their debridement procedure. Of these, 5 patients required a repeat debridement of their medial or lateral gutters for a failure rate of 11.4%.Both arthroscopic and open treatment of impingement after total ankle arthroplasty are safe and effective in improving function and pain. Although the rates for revision impingement surgery are higher in arthroscopic compared with open procedures, they are not significantly so. Therefore, we recommend arthroscopic surgery whenever possible because of earlier time to weight bearing and mobility.Level IV.

Full Text

Duke Authors

Cited Authors

  • Gross, CE; Adams, SB; Easley, M; Nunley, JA; DeOrio, JK

Published Date

  • February 2017

Published In

Volume / Issue

  • 10 / 1

Start / End Page

  • 37 - 42

PubMed ID

  • 27595854

Pubmed Central ID

  • 27595854

Electronic International Standard Serial Number (EISSN)

  • 1938-7636

International Standard Serial Number (ISSN)

  • 1938-6400

Digital Object Identifier (DOI)

  • 10.1177/1938640016666918

Language

  • eng